Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108


Underutilization of aspirin for primary prevention of cardiovascular disease among HIV-infected patients.

Burkholder GA, Tamhane AR, Salinas JL, Mugavero MJ, Raper JL, Westfall AO, Saag MS, Willig JH.

Clin Infect Dis. 2012 Dec;55(11):1550-7. doi: 10.1093/cid/cis752. Epub 2012 Aug 31.


Aspirin Use in Adults: Cancer, All-Cause Mortality, and Harms: A Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet].

Whitlock EP, Williams SB, Burda BU, Feightner A, Beil T.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2015 Sep.


Coronary artery disease risk reduction in HIV-infected persons: a comparative analysis.

Okeke NL, Chin T, Clement M, Chow SC, Hicks CB.

AIDS Care. 2016;28(4):475-82. doi: 10.1080/09540121.2015.1099602. Epub 2015 Oct 19.


Use of aspirin and statins for the primary prevention of myocardial infarction and stroke in patients with human immunodeficiency virus infection.

Park TE, Yusuff J, Sharma R.

Int J STD AIDS. 2016 May;27(6):447-52. doi: 10.1177/0956462415585448. Epub 2015 May 7.


A national survey on aspirin patterns of use and persistence in community outpatients in Italy.

Filippi A, Bianchi C, Parazzini F, Cricelli C, Sessa E, Mazzaglia G.

Eur J Cardiovasc Prev Rehabil. 2011 Oct;18(5):695-703. doi: 10.1177/1741826710397850. Epub 2011 Mar 1.


Statins and Aspirin use in HIV-infected people: gap between European AIDS Clinical Society guidelines and clinical practice: the results from HIV-HY study.

De Socio GV, Ricci E, Parruti G, Calza L, Maggi P, Celesia BM, Orofino G, Madeddu G, Martinelli C, Menzaghi B, Taramasso L, Penco G, Carenzi L, Franzetti M, Bonfanti P.

Infection. 2016 Oct;44(5):589-97. doi: 10.1007/s15010-016-0893-z. Epub 2016 Apr 5.


Aspirin for primary prevention in patients with diabetes mellitus.

Nguyen KX, Marinac JS, Sun C.

Fam Med. 2005 Feb;37(2):112-7.


Cardiovascular disease guideline adherence and self-reported statin use in longstanding type 1 diabetes: results from the Canadian study of longevity in diabetes cohort.

Bai JW, Boulet G, Halpern EM, Lovblom LE, Eldelekli D, Keenan HA, Brent M, Paul N, Bril V, Cherney DZ, Weisman A, Perkins BA.

Cardiovasc Diabetol. 2016 Jan 25;15:14. doi: 10.1186/s12933-015-0318-9.


Do clinicians recommend aspirin to patients for primary prevention of cardiovascular disease?

Fiscella K, Winters PC, Mendoza M, Noronha GJ, Swanger CM, Bisognano JD, Fortuna RJ.

J Gen Intern Med. 2015 Feb;30(2):155-60. doi: 10.1007/s11606-014-2985-8.


Cardiovascular disease risk among Chinese antiretroviral-naïve adults with advanced HIV disease.

Guo F, Hsieh E, Lv W, Han Y, Xie J, Li Y, Song X, Li T.

BMC Infect Dis. 2017 Apr 20;17(1):287. doi: 10.1186/s12879-017-2358-0.


Aspirin for prophylactic use in the primary prevention of cardiovascular disease and cancer: a systematic review and overview of reviews.

Sutcliffe P, Connock M, Gurung T, Freeman K, Johnson S, Kandala NB, Grove A, Gurung B, Morrow S, Clarke A.

Health Technol Assess. 2013 Sep;17(43):1-253. doi: 10.3310/hta17430. Review.


Predictors and time trends in clopidogrel and proton pump inhibitor coprescription with low-dose acetylsalicylic acid.

Cea Soriano L, Bueno H, Johansson S, García Rodríguez LA.

Pharmacoepidemiol Drug Saf. 2012 May;21(5):463-9. doi: 10.1002/pds.3195. Epub 2012 Feb 1.


Discrepancies in cardiovascular disease risk calculation affect aspirin use recommendations in patients with diabetes.

Diaz VA, Dickerson LM, Smith LL, Seawright K, Wessell A, Gavin JK, Chirina S, Knoll M, Player MS, McCutcheon A.

South Med J. 2014 Jun;107(6):368-73. doi: 10.14423/01.SMJ.0000450709.46174.34.


Frequency and practice-level variation in inappropriate aspirin use for the primary prevention of cardiovascular disease: insights from the National Cardiovascular Disease Registry's Practice Innovation and Clinical Excellence registry.

Hira RS, Kennedy K, Nambi V, Jneid H, Alam M, Basra SS, Ho PM, Deswal A, Ballantyne CM, Petersen LA, Virani SS.

J Am Coll Cardiol. 2015 Jan 20;65(2):111-21. doi: 10.1016/j.jacc.2014.10.035.


Comparison of Recommended Eligibility for Primary Prevention Statin Therapy Based on the US Preventive Services Task Force Recommendations vs the ACC/AHA Guidelines.

Pagidipati NJ, Navar AM, Mulder H, Sniderman AD, Peterson ED, Pencina MJ.

JAMA. 2017 Apr 18;317(15):1563-1567. doi: 10.1001/jama.2017.3416.


Compliance with USPSTF recommendations on aspirin for prevention of cardiovascular disease in men.

Malayala SV, Raza A.

Int J Clin Pract. 2016 Nov;70(11):898-906. doi: 10.1111/ijcp.12869. Epub 2016 Sep 12.


Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement.

Bibbins-Domingo K; U.S. Preventive Services Task Force.

Ann Intern Med. 2016 Jun 21;164(12):836-45. doi: 10.7326/M16-0577. Epub 2016 Apr 12.


Supplemental Content

Support Center